Literature DB >> 16920571

B cells and autoimmune liver diseases.

Yuki Moritoki1, Zhe-Xiong Lian, Yoshiyuki Ohsugi, Yoshiyuki Ueno, M Eric Gershwin.   

Abstract

Autoimmune hepatitis (AIH), primary biliary cirrhosis (PBC) and primary sclerosing cholangitis (PSC) are the three major autoimmune diseases affecting the liver. They are all characterized by the presence of a variety of autoantibodies, some of which are found in all three diseases, whereas others are restricted to one or two of them or are even specific for the particular disease. In this review we will first provide details of the serological features of these three autoimmune diseases that target the liver. In addition, we will highlight the possible pathogenic roles of autoreactive B cells, focusing on their immunological functions as autoantibody producing cells and as antigen-presenting cells for T cell priming. As well, we will describe the contribution of toll-like receptor (TLR) signaling to the activation of autoimmune B cells and the putative role of defects in regulatory T cell function in the development of autoimmune liver diseases.

Entities:  

Mesh:

Year:  2006        PMID: 16920571     DOI: 10.1016/j.autrev.2006.02.006

Source DB:  PubMed          Journal:  Autoimmun Rev        ISSN: 1568-9972            Impact factor:   9.754


  9 in total

Review 1.  Autophagy: highlighting a novel player in the autoimmunity scenario.

Authors:  Ana Lleo; Pietro Invernizzi; Carlo Selmi; Ross L Coppel; Gianfranco Alpini; Mauro Podda; Ian R Mackay; M Eric Gershwin
Journal:  J Autoimmun       Date:  2007-08-10       Impact factor: 7.094

2.  In situ mass spectrometry of autoimmune liver diseases.

Authors:  Christopher L Bowlus; Erin H Seeley; Joanna Roder; Julia Grigorieva; Heinrich Roder; Richard M Caprioli; Meric Gershwin
Journal:  Cell Mol Immunol       Date:  2011-01-24       Impact factor: 11.530

Review 3.  Primary biliary cirrhosis: what we know and what we want to know about human PBC and spontaneous PBC mouse models.

Authors:  Yoshiyuki Ueno; Yuki Moritoki; Tooru Shimosegawa; M Eric Gershwin
Journal:  J Gastroenterol       Date:  2007-03-30       Impact factor: 7.527

4.  Autoimmune hepatitis: new paradigms in the pathogenesis, diagnosis, and management.

Authors:  Ye H Oo; Stefan G Hubscher; David H Adams
Journal:  Hepatol Int       Date:  2010-05-19       Impact factor: 6.047

Review 5.  Primary sclerosing cholangitis--what is the difference between east and west?

Authors:  Ali Shorbagi; Yusuf Bayraktar
Journal:  World J Gastroenterol       Date:  2008-07-07       Impact factor: 5.742

6.  Anti-alpha-actinin antibodies cross-react with anti-ssDNA antibodies in active autoimmune hepatitis.

Authors:  Yves Renaudineau; Geogios N Dalekos; Paul Guéguen; Kalliopi Zachou; Pierre Youinou
Journal:  Clin Rev Allergy Immunol       Date:  2008-06       Impact factor: 8.667

7.  Clinicopathological study of primary biliary cirrhosis with interface hepatitis compared to autoimmune hepatitis.

Authors:  Mio Kobayashi; Yuko Kakuda; Kenichi Harada; Yasunori Sato; Motoko Sasaki; Hiroko Ikeda; Mitsuhiro Terada; Munenori Mukai; Shuichi Kaneko; Yasuni Nakanuma
Journal:  World J Gastroenterol       Date:  2014-04-07       Impact factor: 5.742

Review 8.  The Role of B Cells in Adult and Paediatric Liver Injury.

Authors:  Arzoo M Patel; Yuxin S Liu; Scott P Davies; Rachel M Brown; Deirdre A Kelly; Dagmar Scheel-Toellner; Gary M Reynolds; Zania Stamataki
Journal:  Front Immunol       Date:  2021-09-23       Impact factor: 8.786

9.  Increased Incidence of Post-transplant Lymphoproliferative Disorder in Autoimmune Liver Disease: An Irish National Experience.

Authors:  Ahmed Abu-Shanab; Yasser Ged; Naeem Ullah; Diarmaid Houlihan; Aiden McCormick
Journal:  J Clin Exp Hepatol       Date:  2017-06-15
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.